The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Savill Corrine since 2022.
This trader's CIK number is 1837524.
At the time of last reporting, Savill Corrine was the Chief Business Officer of Cullinan Oncology, Inc.. (stock ticker symbol CGEM).
Also see all insider trading activities at Cullinan Oncology, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | CGEM | 0 | $0 | 120,000 | $1,702,473 | 115,875 | $498,261 |
| 2022 | CGEM | 0 | $0 | 60,000 | $847,192 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-02-01 | CGEM | Sale | 40,000 | 16.18 | 647,200 |
| 2024-02-01 | CGEM | Option Ex | 40,000 | 4.30 | 172,000 |
| 2024-01-29 | CGEM | Option Ex | 40,000 | 4.30 | 172,000 |
| 2024-01-29 | CGEM | Sale | 40,000 | 14.09 | 563,600 |
| 2024-01-22 | CGEM | Option Ex | 14,559 | 4.30 | 62,603 |
| 2024-01-23 | CGEM | Option Ex | 21,316 | 4.30 | 91,658 |
| 2024-01-22 | CGEM | Sale | 18,684 | 12.10 | 226,076 |
| 2024-01-23 | CGEM | Sale | 21,316 | 12.46 | 265,597 |
| 2022-07-18 | CGEM | Sale | 5,042 | 15.06 | 75,932 |
| 2022-07-19 | CGEM | Sale | 14,958 | 15.22 | 227,660 |
| 2022-07-11 | CGEM | Sale | 40,000 | 13.59 | 543,600 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Savill Corrine (Chief Business Officer of Cullinan Oncology, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.